{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:26:56Z","timestamp":1792891616424,"version":"4.5.0"},"reference-count":52,"publisher":"Zhejiang University Press","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1631\/jzus.b2300182","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T15:02:09Z","timestamp":1720623729000},"page":"568-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Human umbilical cord mesenchymal stem cells attenuate diabetic nephropathy through the IGF1R-CHK2-p53 signalling axis in male rats with type 2 diabetes mellitus","\u4eba\u8110\u5e26\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u901a\u8fc7 IGF1R-CHK2-p53 \u4fe1\u53f7\u8f74\u51cf\u8f7b 2 \u578b\u7cd6\u5c3f\u75c5\u96c4\u6027\u5927\u9f20\u7cd6\u5c3f\u75c5\u80be\u75c5"],"prefix":"10.1631","volume":"25","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yierfan","family":"Abuduaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayinaer","family":"Jieensihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xishuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuojin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-4853","authenticated-orcid":false,"given":"Zhaosheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9592-414X","authenticated-orcid":false,"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"9","key":"753_CR1","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.biocel.2007.04.013","volume":"39","author":"A Adaikalakoteswari","year":"2007","unstructured":"Adaikalakoteswari A, Rema M, Mohan V, et al., 2007. Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase\/nuclear factor-kappa B signaling in patients with Type 2 diabetes and microangiopathy. Int J Biochem Cell Biol, 39(9):1673\u20131684. https:\/\/doi.org\/10.1016\/j.biocel.2007.04.013","journal-title":"Int J Biochem Cell Biol"},{"issue":"7845","key":"753_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41586-021-03225-8","volume":"590","author":"Ansarullah","year":"2021","unstructured":"Ansarullah, Jain C, Far FF, et al., 2021. Inceptor counteracts insulin signalling in \u03b2-cells to control glycaemia. Nature, 590(7845):326\u2013331. https:\/\/doi.org\/10.1038\/s41586-021-03225-8","journal-title":"Nature"},{"issue":"24","key":"753_CR3","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1128\/MCB.00347-10","volume":"30","author":"HL Armata","year":"2010","unstructured":"Armata HL, Golebiowski D, Jung DY, et al., 2010. Requirement of the ATM\/p53 tumor suppressor pathway for glucose homeostasis. Mol Cell Biol, 30(24):5787\u20135794. https:\/\/doi.org\/10.1128\/mcb.00347-10","journal-title":"Mol Cell Biol"},{"issue":"4","key":"753_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE, 2013. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell, 13(4):392\u2013402. https:\/\/doi.org\/10.1016\/j.stem.2013.09.006","journal-title":"Cell Stem Cell"},{"issue":"6772","key":"753_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/35002510","volume":"403","author":"SD Bruner","year":"2000","unstructured":"Bruner SD, Norman DP, Verdine GL, 2000. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature, 403(6772):859\u2013866. https:\/\/doi.org\/10.1038\/35002510","journal-title":"Nature"},{"issue":"5","key":"753_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2337\/diacare.26.5.1589","volume":"26","author":"A Ceriello","year":"2003","unstructured":"Ceriello A, 2003. New insights on oxidative stress and diabetic complications may lead to a \u201ccausal\u201d antioxidant therapy. Diabetes Care, 26(5):1589\u20131596. https:\/\/doi.org\/10.2337\/diacare.26.5.1589","journal-title":"Diabetes Care"},{"issue":"20","key":"753_CR7","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1158\/1078-0432.CCR-07-4879","volume":"14","author":"MM Chitnis","year":"2008","unstructured":"Chitnis MM, Yuen JSP, Protheroe AS, et al., 2008. The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res, 14(20):6364\u20136370. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-4879","journal-title":"Clin Cancer Res"},{"issue":"4","key":"753_CR8","first-page":"82","volume":"7","author":"J Cho","year":"2018","unstructured":"Cho J, D\u2019Antuono M, Glicksman M, et al., 2018. A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus. Am J Stem Cells, 7(4): 82\u201393.","journal-title":"Am J Stem Cells"},{"issue":"2","key":"753_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/153537020523000208","volume":"230","author":"V Cingel-Ristic","year":"2005","unstructured":"Cingel-Ristic V, Schrijvers BF, van Vliet AK, et al., 2005. Kidney growth in normal and diabetic mice is not affected by human insulin-like growth factor binding protein-1 administration. Exp Biol Med, 230(2):135\u2013143. https:\/\/doi.org\/10.1177\/153537020523000208","journal-title":"Exp Biol Med"},{"issue":"3","key":"753_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0891-5849(98)00053-7","volume":"25","author":"AR Collins","year":"1998","unstructured":"Collins AR, Ra\u0161lov\u00e1 K, Somorovsk\u00e1 M, et al., 1998. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med, 25(3):373\u2013377. https:\/\/doi.org\/10.1016\/s0891-5849(98)00053-7","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"753_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3727\/096368915X686841","volume":"24","author":"DC Ding","year":"2015","unstructured":"Ding DC, Chang YH, Shyu WC, et al., 2015. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant, 24(3):339\u2013347. https:\/\/doi.org\/10.3727\/096368915x686841","journal-title":"Cell Transplant"},{"issue":"7","key":"753_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1172\/JCI18127","volume":"112","author":"XL Du","year":"2003","unstructured":"Du XL, Matsumura T, Edelstein D, et al., 2003. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest, 112(7):1049\u20131057. https:\/\/doi.org\/10.1172\/jci18127","journal-title":"J Clin Invest"},{"issue":"6","key":"753_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/BF00404636","volume":"33","author":"A Flyvbjerg","year":"1990","unstructured":"Flyvbjerg A, Bornfeldt KE, Marshall SM, et al., 1990. Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia, 33(6):334\u2013338. https:\/\/doi.org\/10.1007\/bf00404636","journal-title":"Diabetologia"},{"issue":"2","key":"753_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, Whiting DR, Hambleton I, et al., 2014. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract, 103(2):137\u2013149. https:\/\/doi.org\/10.1016\/j.diabres.2013.11.002","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"753_CR15","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.3390\/cells10123371","volume":"10","author":"E Gurevich","year":"2021","unstructured":"Gurevich E, Segev Y, Landau D, 2021. Growth hormone and IGF1 actions in kidney development and function. Cells, 10(12):3371. https:\/\/doi.org\/10.3390\/cells10123371","journal-title":"Cells"},{"issue":"3","key":"753_CR16","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2337\/diabetes.52.3.846","volume":"52","author":"AD Hodgkinson","year":"2003","unstructured":"Hodgkinson AD, Bartlett T, Oates PJ, et al., 2003. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes, 52(3):846\u2013851. https:\/\/doi.org\/10.2337\/diabetes.52.3.846","journal-title":"Diabetes"},{"issue":"3","key":"753_CR17","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.3892\/mmr.2017.8311","volume":"17","author":"HY Jia","year":"2018","unstructured":"Jia HY, Yan YM, Liang ZF, et al., 2018. Autophagy: a new treatment strategy for MSC-based therapy in acute kidney injury (Review). Mol Med Rep, 17(3):3439\u20133447. https:\/\/doi.org\/10.3892\/mmr.2017.8311","journal-title":"Mol Med Rep"},{"issue":"2","key":"753_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/aps.2015.128","volume":"37","author":"YL Kong","year":"2016","unstructured":"Kong YL, Shen Y, Ni J, et al., 2016. Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1\/IGF-1R pathway. Acta Pharmacol Sin, 37(2):217\u2013227. https:\/\/doi.org\/10.1038\/aps.2015.128","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"753_CR19","doi-asserted-by":"publisher","first-page":"e11217","DOI":"10.15252\/emmm.201911217","volume":"12","author":"\u00c1 Lahiguera","year":"2020","unstructured":"Lahiguera \u00c1, Hyro\u0161\u0161ov\u00e1 P, Figueras A, et al., 2020. Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors. EMBO Mol Med, 12(6):e11217. https:\/\/doi.org\/10.15252\/emmm.201911217","journal-title":"EMBO Mol Med"},{"issue":"2","key":"753_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1523-1755.2001.060002505.x","volume":"60","author":"D Landau","year":"2001","unstructured":"Landau D, Segev Y, Afargan M, et al., 2001. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse. Kidney Int, 60(2):505\u2013512. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.060002505.x","journal-title":"Kidney Int"},{"issue":"1","key":"753_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12020-009-9190-2","volume":"36","author":"D Landau","year":"2009","unstructured":"Landau D, Eshet R, Troib A, et al., 2009. Increased renal Akt\/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation. Endocrine, 36(1): 126\u2013134. https:\/\/doi.org\/10.1007\/s12020-009-9190-2","journal-title":"Endocrine"},{"issue":"4","key":"753_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.afos.2018.11.083","volume":"4","author":"SH Lee","year":"2018","unstructured":"Lee SH, 2018. The advantages and limitations of mesenchymal stem cells in clinical application for treating human diseases. Osteoporos Sarcopenia, 4(4):150. https:\/\/doi.org\/10.1016\/j.afos.2018.11.083","journal-title":"Osteoporos Sarcopenia"},{"issue":"1","key":"753_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0014-5793(97)01273-8","volume":"417","author":"J Leinonen","year":"1997","unstructured":"Leinonen J, Lehtim\u00e4ki T, Toyokuni S, et al., 1997. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett, 417(1): 150\u2013152. https:\/\/doi.org\/10.1016\/s0014-5793(97)01273-8","journal-title":"FEBS Lett"},{"key":"753_CR24","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.2147\/DDDT.S171638","volume":"12","author":"JY Li","year":"2018","unstructured":"Li JY, Dong R, Yu JL, et al., 2018. Inhibitor of IGF1 receptor alleviates the inflammation process in the diabetic kidney mouse model without activating SOCS2. Drug Des Devel Ther, 12:2887\u20132896. https:\/\/doi.org\/10.2147\/dddt.S171638","journal-title":"Drug Des Devel Ther"},{"issue":"8","key":"753_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.molonc.2016.06.002","volume":"10","author":"MM Loesch","year":"2016","unstructured":"Loesch MM, Collier AE, Southern DH, et al., 2016. Insulin-like growth factor-1 receptor regulates repair of ultraviolet B-induced DNA damage in human keratinocytes in vivo. Mol Oncol, 10(8):1245\u20131254. https:\/\/doi.org\/10.1016\/j.molonc.2016.06.002","journal-title":"Mol Oncol"},{"issue":"5","key":"753_CR26","doi-asserted-by":"publisher","first-page":"495.e9","DOI":"10.1016\/j.ajog.2010.06.045","volume":"203","author":"MI Macias","year":"2010","unstructured":"Macias MI, Grande J, Moreno A, et al., 2010. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol, 203(5):495.e9\u2013495.e23. https:\/\/doi.org\/10.1016\/j.ajog.2010.06.045","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"753_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0022034516677529","volume":"96","author":"S Meyer","year":"2017","unstructured":"Meyer S, Chibly AM, Burd R, et al., 2017. Insulin-like growth factor-1-mediated DNA repair in irradiated salivary glands is sirtuin-1 dependent. J Dent Res, 96(2):225\u2013232. https:\/\/doi.org\/10.1177\/0022034516677529","journal-title":"J Dent Res"},{"key":"753_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s13287-021-02447-x","volume":"12","author":"P Nie","year":"2021","unstructured":"Nie P, Bai X, Lou Y, et al., 2021. Human umbilical cord mesenchymal stem cells reduce oxidative damage and apoptosis in diabetic nephropathy by activating Nrf2. Stem Cell Res Ther, 12:450. https:\/\/doi.org\/10.1186\/s13287-021-02447-x","journal-title":"Stem Cell Res Ther"},{"issue":"6779","key":"753_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Du XL, et al., 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404(6779):787\u2013790. https:\/\/doi.org\/10.1038\/35008121","journal-title":"Nature"},{"issue":"6","key":"753_CR30","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/ki.1991.312","volume":"40","author":"MS Paller","year":"1991","unstructured":"Paller MS, Neumann TV, 1991. Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygenation. Kidney Int, 40(6):1041\u201310499. https:\/\/doi.org\/10.1038\/ki.1991.312","journal-title":"Kidney Int"},{"issue":"2","key":"753_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tcm.2006.11.005","volume":"17","author":"CA Papaharalambus","year":"2007","unstructured":"Papaharalambus CA, Griendling KK, 2007. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med, 17(2):48\u201354. https:\/\/doi.org\/10.1016\/j.tcm.2006.11.005","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"753_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12630-011-9493-7","volume":"58","author":"SR Pestieau","year":"2011","unstructured":"Pestieau SR, Quezado ZMN, Johnson YJ, et al., 2011. Highdose dexmedetomidine increases the opioid-free interval and decreases opioid requirement after tonsillectomy in children. Can J Anaesth, 58(6):540\u2013550. https:\/\/doi.org\/10.1007\/s12630-011-9493-7","journal-title":"Can J Anaesth"},{"key":"753_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13287-019-1362-2","volume":"10","author":"YC Qi","year":"2019","unstructured":"Qi YC, Ma J, Li SX, et al., 2019. Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes. Stem Cell Res Ther, 10:274. https:\/\/doi.org\/10.1186\/s13287-019-1362-2","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"753_CR34","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/ndt\/gfg170","volume":"18","author":"I Raz","year":"2003","unstructured":"Raz I, Wexler I, Weiss O, et al., 2003. Role of insulin and the IGF system in renal hypertrophy in diabetic Psammomys obesus (sand rat). Nephrol Dial Transplant, 18(7):1293\u20131298. https:\/\/doi.org\/10.1093\/ndt\/gfg170","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"753_CR35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.7150\/ijms.8034","volume":"11","author":"M R\u00edos-Silva","year":"2014","unstructured":"R\u00edos-Silva M, Trujillo X, Trujillo-Hern\u00e1ndez B, et al., 2014. Effect of chronic administration of forskolin on glycemia and oxidative stress in rats with and without experimental diabetes. Int J Med Sci, 11(5):448\u2013452. https:\/\/doi.org\/10.7150\/ijms.8034","journal-title":"Int J Med Sci"},{"issue":"3","key":"753_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1681\/ASN.V83436","volume":"8","author":"Y Segev","year":"1997","unstructured":"Segev Y, Landau D, Marbach M, et al., 1997. Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor I. J Am Soc Nephrol, 8(3):436\u2013444. https:\/\/doi.org\/10.1681\/asn.V83436","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"753_CR37","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2337\/db11-1141","volume":"61","author":"YL Si","year":"2012","unstructured":"Si YL, Zhao YL, Hao HJ, et al., 2012. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes, 61(6): 1616\u20131625. https:\/\/doi.org\/10.2337\/db11-1141","journal-title":"Diabetes"},{"issue":"4","key":"753_CR38","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.3892\/mmr.2015.4214","volume":"12","author":"E Sohn","year":"2015","unstructured":"Sohn E, Kim J, Kim CS, et al., 2015. Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin-induced diabetic rats and its active compound emodin inhibits methylglyoxal-mediated glycation of proteins. Mol Med Rep, 12(4):5837\u20135845. https:\/\/doi.org\/10.3892\/mmr.2015.4214","journal-title":"Mol Med Rep"},{"issue":"5","key":"753_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ghir.2011.07.007","volume":"21","author":"A Troib","year":"2011","unstructured":"Troib A, Landau D, Youngren JF, et al., 2011. The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease. Growth Horm IGF Res, 21(5):285\u2013291. https:\/\/doi.org\/10.1016\/j.ghir.2011.07.007","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"753_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.radonc.2012.03.009","volume":"103","author":"BW Turney","year":"2012","unstructured":"Turney BW, Kerr M, Chitnis MM, et al., 2012. Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks. Radiother Oncol, 103(3):402\u2013409. https:\/\/doi.org\/10.1016\/j.radonc.2012.03.009","journal-title":"Radiother Oncol"},{"issue":"2","key":"753_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.diabres.2006.09.012","volume":"76","author":"TL Vasylyeva","year":"2007","unstructured":"Vasylyeva TL, Ferry RJ, 2007. Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy. Diabetes Res Clin Pract, 76(2):177\u2013186. https:\/\/doi.org\/10.1016\/j.diabres.2006.09.012","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"753_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jphs.2021.06.008","volume":"147","author":"HY Wu","year":"2021","unstructured":"Wu HY, Zhang XC, Jia BB, et al., 2021. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acetaminophen-induced acute liver failure through activating ERK and IGF-1R\/PI3K\/AKT signaling pathway. J Pharmacol Sci, 147(1):143\u2013155. https:\/\/doi.org\/10.1016\/j.jphs.2021.06.008","journal-title":"J Pharmacol Sci"},{"key":"753_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","volume":"11","author":"E Xiang","year":"2020","unstructured":"Xiang E, Han B, Zhang Q, et al., 2020. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther, 11:336. https:\/\/doi.org\/10.1186\/s13287-020-01852-y","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"753_CR44","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bbrc.2016.12.125","volume":"483","author":"M Xie","year":"2017","unstructured":"Xie M, Hao HJ, Cheng Y, et al., 2017. Adipose-derived mesenchymal stem cells ameliorate hyperglycemia through regulating hepatic glucose metabolism in type 2 diabetic rats. Biochem Biophys Res Commun, 483(1):435\u2013441. https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.125","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"753_CR45","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/stem.2238","volume":"34","author":"ZY Xie","year":"2016","unstructured":"Xie ZY, Hao HJ, Tong C, et al., 2016. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. Stem Cells, 34(3):627\u2013639. https:\/\/doi.org\/10.1002\/stem.2238","journal-title":"Stem Cells"},{"issue":"2","key":"753_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1631\/jzus.B2200410","volume":"24","author":"YZ Xu","year":"2023","unstructured":"Xu YZ, Fan P, Liu L, et al., 2023. Novel perspective in transplantation therapy of mesenchymal stem cells: TArgeting the ferroptosis pathway. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 24(2):115\u2013129. https:\/\/doi.org\/10.1631\/jzus.B2200410","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"5","key":"753_CR47","doi-asserted-by":"publisher","first-page":"F1144","DOI":"10.1152\/ajprenal.00094.2005","volume":"289","author":"S Yang","year":"2005","unstructured":"Yang S, Chintapalli J, Sodagum L, et al., 2005. Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol, 289(5):F1144\u2013F1152. https:\/\/doi.org\/10.1152\/ajprenal.00094.2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"753_CR48","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/pharmaceutics14030649","volume":"14","author":"SK Yap","year":"2022","unstructured":"Yap SK, Tan KL, Abd Rahaman NY, et al., 2022. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorated insulin resistance in type 2 diabetes mellitus rats. Pharmaceutics, 14(3):649. https:\/\/doi.org\/10.3390\/pharmaceutics14030649","journal-title":"Pharmaceutics"},{"issue":"6","key":"753_CR49","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00210-017-1360-9","volume":"390","author":"EM Zakaria","year":"2017","unstructured":"Zakaria EM, El-Maraghy NN, Ahmed AF, et al., 2017. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis. Naunyn-Schmiedeberg\u2019s Arch Pharmacol, 390(6):621\u2013631. https:\/\/doi.org\/10.1007\/s00210-017-1360-9","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"753_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-022-02855-7","volume":"13","author":"YQ Zhang","year":"2022","unstructured":"Zhang YQ, Le X, Zheng S, et al., 2022. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization. Stem Cell Res Ther, 13:171. https:\/\/doi.org\/10.1186\/s13287-022-02855-7","journal-title":"Stem Cell Res Ther"},{"key":"753_CR51","doi-asserted-by":"publisher","first-page":"5584894","DOI":"10.1155\/2023\/5584894","volume":"2023","author":"S Zheng","year":"2023","unstructured":"Zheng S, Zhang K, Zhang YQ, et al., 2023. Human umbilical cord mesenchymal stem cells inhibit pyroptosis of renal tubular epithelial cells through miR-342-3p\/caspase1 signaling pathway in diabetic nephropathy. Stem Cells Int, 2023:5584894. https:\/\/doi.org\/10.1155\/2023\/5584894","journal-title":"Stem Cells Int"},{"issue":"4","key":"753_CR52","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jvs.2016.03.407","volume":"65","author":"X Zhou","year":"2017","unstructured":"Zhou X, Patel D, Sen S, et al., 2017. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis. J Vasc Surg, 65(4): 1161\u20131169. https:\/\/doi.org\/10.1016\/j.jvs.2016.03.407","journal-title":"J Vasc Surg"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2300182\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T04:01:45Z","timestamp":1721793705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2300182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2300182","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hao ZHANG, Xinshu WANG, Bo HU, Peicheng LI, Yierfan ABUDUAINI, Hongmei ZHAO, Ayinaer JIEENSIHAN, Xishuang CHEN, Shiyu WANG, Nuojin GUO, Jian YUAN, Yunhui LI, Lei LI, Yuntong YANG, Zhongmin LIU, Zhaosheng TANG, and Hua WANG declare that there are no potential conflicts of interest in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"All experimental procedures were approved by the Ethics Committee of Animal Experiments of Shanghai Zhanyuan Biotechnology Co., Ltd. (cooperative unit of Tongji University, Shanghai, China) (No. SHCQ-20200102). This study was carried out in strict accordance with internationally accepted guidelines regarding animal welfare and was conducted according to the guidelines of the Chinese Council on Animal Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}